Cuba to Complete Trials of Soberana 01 Vaccine in Early 2021 against Covid-19.
The Center for State Control of Medicines, Equipment and Medical Devices (Cecmed) has approved the submission of a prophylactic drug against the SARS-CoV-2 coronavirus, developed by the Finlay Institute of Vaccines, for Phase I / II studies. The process will begin on August 24th and end on January 11, 2021, according to the Cuban Public Registry of Clinical Trials website. Cuba should conclude clinical trials of "Soberana 01" - a vaccine candidate against COVID-19 - by early next year.




